Appia Bio

Appia Bio

Biotechnology Research 27 employees
Employees
27
Contacts
4
Emails
4
Phones
4

Appia Bio Overview

Website
appiabio.com
Industry
Biotechnology Research
Employees
27
Founded
2020
Funding
52.0M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Appia Bio

Appia Bio is an early stage biotechnology company based in Los Angeles, California. Founded in 2020, Appia Bio is focused on discovering and developing engineered allogeneic cell therapies across a broad array of indications with a scalable technology platform that increases access for patients. With its ACUA (Appia Cells Utilized for Allogeneic) technology platform, Appia Bio leverages the biology of lymphocyte development with chimeric antigen receptor (CAR) and T-cell receptor (TCR) gene engineering to generate CAR-engineered invariant natural killer T (CAR-iNKT) cell subtypes from hematopoietic stem cells (HSCs).

Appia Bio Contact Details

People in AeroLeads
4
With contact data
4
Email contacts
4
100.0% coverage
Phone contacts
4
100.0% coverage

Appia Bio Org Chart

Sample employees and titles
Name Title Contact
Jason Damiano Chief Scientific Officer at Appia Bio
Email Phone
Shiva Gojgini As an Analytical Development Scientist
Email Phone
Monica Jenkins Mj HR Consulting
Email Phone
Tessa Aglupos-Mccann Sr. Director, Finance
Email Phone

Employees by Management Level

Individual contributor 8 profiles
Senior / Lead 2 profiles
Associate / junior 2 profiles
Executive 1 profile
Director 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 9 8 3
Finance 1 1 1

Appia Bio Tech Stack

Data / AI 7 profiles

Compare Similar Companies to Appia Bio